designer491/iStock via Getty Images
Valneva (VALN) and the world’s largest vaccine maker, Serum Institute of India, announced on Wednesday that they have mutually agreed to discontinue their licensing agreement for the former’s chikungunya vaccine.
The companies identified the decision as a strategic move aimed
Follow us on Google for the latest stock news
On the final day of 2025, three Israeli renewable energy companies signed deals worth a combined NIS 4.5 billion. ...
Trump Mobile, the wireless venture backed by the Trump Organization, has postponed delivery of its long-promised gold-colored T1 smartphone beyond...
The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s...
Robinhood Markets (NASDAQ: HOOD) has arguably been one of the more disruptive names in the stock market during the past...
Research by the Taub Center for Social Policy Studies in Israel indicates a significant shift in patterns of fertility...
Warren Buffett steps down as chief executive of Berkshire Hathaway today, closing one of the longest and most consequential tenures...
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.
